Literature DB >> 21206810

Risk factors in neuroleptic malignant syndrome.

Vinay Gupta1, Rakesh Magon, B P Mishra, G B S Sidhu, Ranjiv Mahajan.   

Abstract

Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.

Entities:  

Keywords:  malignant syndrome; neuroleptic; risk factors

Year:  2003        PMID: 21206810      PMCID: PMC2951537     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  24 in total

1.  Risk factors for neuroleptic malignant syndrome. A case-control study.

Authors:  P E Keck; H G Pope; B M Cohen; S L McElroy; A A Nierenberg
Journal:  Arch Gen Psychiatry       Date:  1989-10

2.  Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital.

Authors:  P E Keck; J Sebastianelli; H G Pope; S L McElroy
Journal:  J Clin Psychiatry       Date:  1989-09       Impact factor: 4.384

3.  Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

Review 4.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

5.  CYP2D6 genotype and possible susceptibility to the neuroleptic malignant syndrome.

Authors:  K Iwahashi
Journal:  Biol Psychiatry       Date:  1994-12-01       Impact factor: 13.382

Review 6.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

7.  Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.

Authors:  H H Harsch
Journal:  J Clin Psychiatry       Date:  1987-08       Impact factor: 4.384

8.  Malignant neuroleptic syndrome--its present status in Japan and clinical problems.

Authors:  H Itoh; N Ohtsuka; K Ogita; G Yagi; S Miura; Y Koga
Journal:  Folia Psychiatr Neurol Jpn       Date:  1977

9.  A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital.

Authors:  A J Gelenberg; B Bellinghausen; J D Wojcik; W E Falk; G S Sachs
Journal:  Am J Psychiatry       Date:  1988-04       Impact factor: 18.112

Review 10.  Pathogenesis and treatment of neuroleptic malignant syndrome.

Authors:  M Ebadi; R F Pfeiffer; L C Murrin
Journal:  Gen Pharmacol       Date:  1990
View more
  4 in total

1.  [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].

Authors:  R Chackupurakal; U Wild; M Kamm; F Wappler; D Reske; S G Sakka
Journal:  Anaesthesist       Date:  2015-06-30       Impact factor: 1.041

2.  Research on antipsychotics in India.

Authors:  Ajit Avasthi; Munish Aggarwal; Sandeep Grover; Mohd Khalid Rasheed Khan
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 3.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

4.  Widening spectrum of neuroleptic malignant syndrome: Case series.

Authors:  Gunchan Paul; Sachi Singhal; Birinder S Paul; Gurparvesh Singh; Shriya Goyal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.